Merck Group in Taiwan picks Taiwan for Asia tech site

TOUGH COMPETITION Taiwan beat out rivals such as Japan and China in the bid to house the Merck facility, which is expected to help boost the biotechnology sector

By Felix Hong / STAFF REPORTER

One of several Taiwanese biotechnology firms present at yesterday's event said it had learned more about potential opportunities to cooperate with DCB.

“The case put forward by DCB looks good, and if costs are acceptable we will probably seek to cooperate with them. The services that Merck and DCB provide certainly helps the process of protein-based drug production,” said

Cheng Li-ting (鄭力廷), a researcher at Sijhih-based Yeastern Biotech Co Ltd (益生生技).